HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by El Mahdani, N.-E. Articles by Chouaib, S. Search for Related Content PubMed PubMed Citation Articles by El Mahdani, N.-E. Articles by Chouaib, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Resistance to TNF-Induced Cytotoxicity Correlates with an Abnormal Cleavage of Cytosolic Phospholipase A₂¹

Nour-Eddine El Mahdani^*, Maya Ameyar^*, Zhenzi Cai^*, Odile Colard, Joëlle Masliah and Salem Chouaib^2,*

^* Institut National de la Santé et de la Recherche Médicale Unité 487, Cytokines et Immunologie des Tumeurs Humaines, Institut Gustave Roussy, Villejuif, France; and Institut de la Santé et de la Recherche Médicale Unité 538, Paris, France

To investigate the mechanism underlying the absence of arachidonic acid (AA) release by TNF in TNF-resistant cells, we first performed comparative analysis of phospholipid pools in both TNF-sensitive (MCF7) and their equivalent resistant cells (C1001). Quantification and incorporation studies of [³H]AA indicated that TNF-resistant cells were not depleted in AA. Furthermore, distribution of this fatty acid in different phospholipid pools was similar in both sensitive cells and their resistant counterparts, ruling out a defect in phospholipid pools. Since phospholipase A₂ (PLA₂) are the main enzymes releasing free AA, we investigated their relative contribution in the acquisition of cell resistance to TNF-induced cell death and AA release. For this purpose, we used two PLA₂ inhibitors, methylarachidonyl fluorophosphate (MAFP) and bromoenol lactone (BEL), which selectively and irreversibly inhibit the cytosolic PLA₂ (cPLA₂) and the Ca²⁺-independent PLA₂, respectively. Although a significant inhibitory effect of MAFP on both TNF-induced AA release and PLA₂ activity in MCF7 was observed, BEL had no effect. The inhibitory effect of MAFP on cPLA₂ activity correlated with an inhibition of TNF-induced cell death. Western blot analysis revealed that TNF induced a differential cleavage of cPLA₂ in TNF-sensitive vs TNF-resistant cells. Although the p70 (70-kDa) form of cPLA₂ was specifically increased in TNF-sensitive cells, a cleaved form, p50 (50 kDa), was selectively observed in TNF-resistant C1001 cells in the presence or absence of TNF. These findings suggest that the acquisition of cell resistance to this cytokine may involve an abnormal cPLA₂ cleavage.

This article has been cited by other articles:

				R. K. Amaravadi and C. B. Thompson The Roles of Therapy-Induced Autophagy and Necrosis in Cancer Treatment Clin. Cancer Res., December 15, 2007; 13(24): 7271 - 7279. [Abstract] [Full Text] [PDF]

				M. Diarra-Mehrpour, S. Arrabal, A. Jalil, X. Pinson, C. Gaudin, G. Pietu, A. Pitaval, H. Ripoche, M. Eloit, D. Dormont, et al. Prion Protein Prevents Human Breast Carcinoma Cell Line from Tumor Necrosis Factor {alpha}-Induced Cell Death Cancer Res., January 15, 2004; 64(2): 719 - 727. [Abstract] [Full Text] [PDF]